Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Biotech
Genentech axes $3B Adaptimmune cell therapy deal
In the same week that Genentech confirmed it's cutting staffers, the company has terminated a cell therapy partnership with Adaptimmune Therapeutics.
Gabrielle Masson
Apr 12, 2024 11:22am
AACR: BioNTech cancer vax spurs immune response 3 years in
Apr 7, 2024 2:00pm
Roche shrinks product development team
Feb 9, 2024 9:30am
Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Jan 23, 2024 7:00am
Roche’s Genentech returns Alzheimer’s assets to AC Immune
Jan 22, 2024 8:47am
Kronos discontinues mid-stage AML trial after poor response
Dec 19, 2023 11:16am